Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Innovotech ( (TSE:IOT) ) has issued an update.
Innovotech Inc. reported strong revenues for the second quarter of 2025, totaling $984,327, and half-year revenues of $2,142,512, despite a second quarter loss of $241,199 due to a one-time executive severance expense. The company acquired intangible assets from BDS Microbial Services Inc., expanding its service offerings and contributing to revenue growth. This acquisition aligns with Innovotech’s focus on long-term profitable growth and strengthens its market position by redirecting clients to its Keystone Labs division.
More about Innovotech
Innovotech Inc. is a diversified Canadian technology company engaged in specialized laboratory services, biotechnology businesses, and proprietary intellectual property. It operates several subsidiary companies, including Innovotech Labs Corporation, which provides antimicrobial testing devices and commercializes antimicrobial silver solutions, and Keystone Labs Inc., a DEL-accredited lab serving the Canadian pharmaceutical and industrial markets. Innovotech also holds a 60% stake in NouLifeSciences Inc., which focuses on antioxidant molecules with potential applications in cosmetics and medical conditions.
Average Trading Volume: 44,335
Technical Sentiment Signal: Strong Buy
Current Market Cap: C$12.02M
For an in-depth examination of IOT stock, go to TipRanks’ Overview page.